Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
controlled substance category
|
| gptkbp:abuseMayLeadTo |
limited physical or psychological dependence
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:definedIn |
gptkb:Controlled_Substances_Act_(United_States)
|
| gptkbp:example |
gptkb:Lomotil
gptkb:Motofen gptkb:Parepectolin gptkb:Lyrica cough preparations with less than 200 mg codeine per 100 ml Ezogabine |
| gptkbp:haveAcceptedMedicalUse |
true
|
| gptkbp:haveLowPotentialForAbuse |
true
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule V drugs
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:lowerAbusePotentialThan |
gptkb:Schedule_IV_drugs
|
| gptkbp:prescribes |
licensed medical practitioners
|
| gptkbp:prescriptionRequired |
yes
|
| gptkbp:refillsAllowed |
yes
|
| gptkbp:regulates |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:bfsParent |
gptkb:Title_II:_Controlled_Substances_Act
gptkb:Controlled_Substances_Act_(US) |
| gptkbp:bfsLayer |
7
|